• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Avient Corporation filed SEC Form 8-K: Leadership Update

    6/3/25 8:40:57 AM ET
    $AVNT
    Major Chemicals
    Industrials
    Get the next $AVNT alert in real time by email
    avnt-20250529
    false000112297600011229762025-05-292025-05-29

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934

    Date of report (Date of earliest event reported): May 29, 2025
    Avient Corporation
    (Exact Name of Registrant as Specified in Its Charter)
    Ohio 1-1609134-1730488
    (State or Other Jurisdiction of Incorporation) (Commission File Number)(IRS Employer Identification No.)

    33587 Walker Road
    Avon Lake, Ohio 44012
    (Address of Principal Executive Offices) (Zip Code)
    Registrant’s telephone number, including area code: (440) 930-1000

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:    
    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))        
    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))        

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Shares, par value $.01 per shareAVNTNew York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Compensatory Agreements of Certain Officers.

    Christopher L. Pederson, Senior Vice President and President of Specialty Engineered Materials, has given notice of his decision to retire from Avient Corporation (the "Company"), effective as of June 30, 2025. A search to find a successor for Mr. Pederson is in progress.



    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    Avient Corporation
    By: /s/ Amy M. Sanders
    Name: Amy M. Sanders
    Title: Senior Vice President, General Counsel and Secretary
    Date: June 3, 2025

    Get the next $AVNT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AVNT

    DatePrice TargetRatingAnalyst
    3/14/2025$43.00Neutral
    Robert W. Baird
    2/18/2025$56.00Neutral → Buy
    Seaport Research Partners
    10/18/2024Buy → Neutral
    Seaport Research Partners
    8/7/2024$49.00 → $52.00Hold → Buy
    Deutsche Bank
    11/6/2023$46.00 → $37.00Buy → Hold
    Deutsche Bank
    2/16/2023$50.00Perform → Outperform
    Oppenheimer
    10/17/2022$40.00Buy
    Deutsche Bank
    9/28/2022Outperform → Perform
    Oppenheimer
    More analyst ratings

    $AVNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Lin Sandra Beach was granted 1,055 shares, increasing direct ownership by 20% to 6,434 units (SEC Form 4)

      4 - AVIENT CORP (0001122976) (Issuer)

      4/2/25 4:14:05 PM ET
      $AVNT
      Major Chemicals
      Industrials
    • Director Wulfsohn William A was granted 1,055 shares (SEC Form 4)

      4 - AVIENT CORP (0001122976) (Issuer)

      4/2/25 3:49:23 PM ET
      $AVNT
      Major Chemicals
      Industrials
    • Director Verduin Patricia was granted 1,055 shares, increasing direct ownership by 5% to 22,679 units (SEC Form 4)

      4 - AVIENT CORP (0001122976) (Issuer)

      4/2/25 3:44:13 PM ET
      $AVNT
      Major Chemicals
      Industrials

    $AVNT
    SEC Filings

    See more
    • SEC Form 11-K filed by Avient Corporation

      11-K - AVIENT CORP (0001122976) (Filer)

      6/17/25 3:34:55 PM ET
      $AVNT
      Major Chemicals
      Industrials
    • Avient Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

      8-K - AVIENT CORP (0001122976) (Filer)

      6/16/25 7:00:21 AM ET
      $AVNT
      Major Chemicals
      Industrials
    • Avient Corporation filed SEC Form 8-K: Leadership Update

      8-K - AVIENT CORP (0001122976) (Filer)

      6/3/25 8:40:57 AM ET
      $AVNT
      Major Chemicals
      Industrials